In a study examining CSF NfL, p-tau, t-tau, and Aβ42 across PSP, CBS, AD, bvFTD, PPA, ALS, and controls, researchers found that ALS patients displayed higher NfL levels than PSP and CBS patients [113]. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.